🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Harmony Biosciences Holdings, Inc.

HRMY Healthcare
$37.98 $-0.29 (-0.76%)
Market Cap: $2.21 B
Gurus Holding
7
Popularity Rank
#1238
% of Shares Held
4.95%
Net Activity (Q2 2026)
+$11.27 M

Guru Ownership Trend

Guru Analysis for Harmony Biosciences Holdings, Inc. (HRMY)

Harmony Biosciences Holdings, Inc. (HRMY), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $109.42 M.

Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $11.27 M net inflow during the quarter.

Recent activity highlights Jefferies Group who opened a new position. Conversely, Joel Greenblatt reduced exposure by 44.1%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$15.85 M
Total Buy Value
New Buys 1
Additions 3
-$4.58 M
Total Sell Value
Reductions 3
Sold Out 2

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
5
Net Buyers
4

FAQs for Harmony Biosciences Holdings, Inc. (HRMY)

Major holders include Renaissance Technologies (RenTech) ($43.52 M), Cliff Asness ($34.02 M), Chuck Royce ($13.2 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 2.88 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $11.27 M, with 4 managers increasing positions and 5 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 2 fully exited HRMY. The total reported sell value was $4.58 M.

Yes, 1 managers opened new positions in HRMY, and 3 increased their existing holdings. The total reported buy value was $15.85 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.06% Add 11.0% 1,195,371 $43.52 M Q2 2026
0.01% Add 30.5% 934,326 $34.02 M Q2 2026
0.11% Add 1.6% 362,464 $13.2 M Q2 2026
0.04% Reduce -1.2% 248,575 $9.05 M Q2 2026
0.02% New Buy 93,400 $3.4 M Q2 2026
0.00% Reduce -44.1% 35,866 $1.31 M Q2 2026
0.00% Reduce -2.6% 10,891 $396,541 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form